Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Related Resources

If you’re attending #INTERPHEX, don’t miss the keynote session ‘Serialization on a Global Scale’ on 20 Oct.

Lauren Catalano joins a panel of global supply chain experts to discuss the US Drug Supply Chain Security Act (DSCSA).

Sign-up here: https://lnkd.in/e5E9WrxB

@INTERPHEX

Are you still managing your drug supply manually? Find out how you can save time with #Clinventory - our self-service, automated Inventory Management System.

Reach out to arrange a short demo and discover the power of Clinventory: https://lnkd.in/eKxDNDdH

The role of the EU Qualified person

Dr Ria Rhemrev from @Sharp_Services will take Manufacturing Chemist Live delegates through the role and its impacts on the end delivery in the supply chain.

Book now: https://bit.ly/3y2qQeZ

#ManChemLive